{"transactions":[{"id":825353,"issuer":{"id":7767,"kind":"organization","name":"NeuroSense Therapeutics Ltd."},"owners":[{"id":55345,"kind":"person","name":"Russek-Blum Niva","position":1,"cik":"0002124437","reported_name":"Russek-Blum Niva","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-30T21:32:00.000Z","date":"2026-03-26","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee or director in connection with the Issuer's 2018 Share Incentive Plan must be registered in the name of a trustee."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date."}],"balance_after":467953,"source":{"system":"sec-edgar","filing":"0001213900-26-036432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875091/000121390026036432/ownership.xml","form_type":"4"}}]}